The Catholic University of Leuven or Louvain was founded in 1834 in Mechelen as the Catholic University of Belgium, and moved its seat to the town of Leuven in 1835, changing its name to Catholic University of Leuven.

During the past decade, Catholic University Leuven conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 3 clinical trials were completed, i.e. on average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Catholic University Leuven" #1 sponsor was "KU Leuven" with 5 trials, followed by "Lung Biotechnology PBC" with 2 trials sponsored, "ZevraDenmark" with 2 trials sponsored, "Dentsply Sirona Implants and Consumables" with 1 trials sponsored and "MedImmune LLC" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Catholic University Leuven" #1 collaborator was "Aarhus University Hospital" with 1 trials as a collaborator, "Academisch Ziekenhuis Groningen" with 1 trials as a collaborator, "Agenzia Nazionale per i Servizi Sanitari Regionali" with 1 trials as a collaborator, "CNAO National Center of Oncological Hadrontherapy" with 1 trials as a collaborator and "Centre Antoine Lacassagne" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Catholic University Leuven" are "Amyotrophic Lateral Sclerosis" (2 trials), "Parkinson's Disease" (2 trials), "Pulmonary Arterial Hypertension" (2 trials), "Barrett Esophagus" (1 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "Catholic University Leuven" in a lesser frequency.

Most popular intervention types in "Catholic University Leuven" are "Drug" (6 trials), "Device" (4 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Arimoclomol" (2 trials), "Beraprost Sodium Modified Release" (2 trials), "Placebo" (2 trials), "Cold-adapted influenza vaccine trivalent (CAIV-T)" (1 trials) and "Epanova" (1 trials). Other intervention names were less common.

The vast majority of trials in "Catholic University Leuven" are 15 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Catholic University Leuven". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Catholic University Leuven, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Catholic University Leuven, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".